References

  1. Reslan OM, Khalil RA. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem. 2010;8(4):204–226. PubMed | Google Scholar

  2. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon ? Immunol Today. 1993 Jul;14(7):353-6. PubMed | Google Scholar

  3. Soeters PB, Grimble RF. The conditional role of inflammation in pregnancy and cancer. Clin Nut. 2013;32(3):460-5. PubMed | Google Scholar

  4. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28(2):192–209. PubMed | Google Scholar

  5. Robertson SA, Bromfield JJ, Tremellen KP. Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis. J Reprod Immunol. 2003;59(2):253–265. PubMed | Google Scholar

  6. Lai Z, Kalkunte S, Sharma S. A Critical Role of Interleukin-10 in Modulating Hypoxia-Induced Preeclampsia-Like Disease in Mice. Hypertension. 2011 Mar;57(3):505-14. PubMed | Google Scholar

  7. Olusi SO, Diejomaoh M, Omu A, Abdulaziz A, Prabha K, George S. Interleukins in preeclampsia. Annals of Saudi Medicine. 2000;20(2):4-8. PubMed | Google Scholar

  8. Afshar JT, Ghomian N, Shameli A, Shakeri M, Fahmidehkar MA,Mahajer E. Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy and Childbirth. 2005;5:14. PubMed | Google Scholar

  9. Romero-Adrián T, Ruiz A, Molina-Vílchez R, Estévez J, Atencio R. Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia. Invest Clin. 2002;43(2):73-78. PubMed | Google Scholar

  10. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction?. Obstet Gynaecol. 1994;84:937-40. PubMed | Google Scholar

  11. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000 Jul;183(1):S1-S22. PubMed | Google Scholar

  12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX-XIV. PubMed | Google Scholar

  13. Wild D. Immunoassay Handbook, Stockton Press, 339;1996. Google Scholar

  14. Teran E , Escudero C, Moya W, Flores M, Vallance P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J of Gynecol and Obst. 2001;75(3):243-49. PubMed | Google Scholar

  15. Hentschke MR, Lucas LS, Krauspenhar B, Raisa P F, Sussela AO, Berlesi F et al. Increased levels of the soluble receptor of Interleukin-6 in patients with preeclampsia compared to normotensive pregnant women. Scientia Medica. 2014;23(4):121-6. PubMed | Google Scholar

  16. Ozler A, Turgut A, Sak ME, Evsen MS, Soydinc HE, Evliyaoglu O et al. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity. Eur Rev Med Pharmacol Sci. 2012;16(12):1707-12. PubMed | Google Scholar

  17. Cui Xie, Mian Zhi Yao, Jiang Bo Liu, Li Kuan Xiong. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011;56(3):550–59. PubMed | Google Scholar

  18. Lau SY, Guild S-J, Barrett CJ, Chen Q, McCowan L, Jordan V, Chamley LW. Tumor necrosis factor-alpha, interleukin-6 and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013 Nov;70(5):412-27. PubMed | Google Scholar

  19. Abbus A, Lichtman A. Cellular and Molecular Immunology. General Properties of the Immune Response, Cells and Tissues of the Immune System. Philadelphia, PA: Elsevier, 2005, p. 189–215. Google Scholar

  20. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997 Mar;37(3):240-9. PubMed | Google Scholar

  21. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest. 1994;93:17–25. PubMed | Google Scholar

  22. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40(2):102–111. PubMed | Google Scholar

  23. Wesselman JP, De Mey JG. Angiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep. 2002;4(1):63–70. PubMed | Google Scholar

  24. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. PubMed | Google Scholar

  25. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality: a population-based, prospective study. Thromb Haemost. 2006 Mar;95(3):511-8. PubMed | Google Scholar

  26. Roberts JM. Endothelial dysfuncion in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):5-15. PubMed | Google Scholar

  27. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007 Aug;18(8):2281-4. PubMed | Google Scholar

  28. Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, Sulaman M. Liver function tests in preeclampsia. J Ayub Med Coll Abbottabad. 2011;23(4):3-5. PubMed | Google Scholar

  29. Udenze IC, Arikawe AP, Azinge EC, Egbuagha EU. Liver function tests in Nigerian women with severe preeclampsia. J Clin Sci. 2014;11(1):7-11. PubMed | Google Scholar

  30. Rolfes DB, Ishak KG. Liver disease in toxaemia of pregnancy. Am J Gastroenterol. 1986;81(12):1138–1144. PubMed | Google Scholar

  31. Duricic S, Stojanov M, Obradovic I, Glicic A, Plecas D. Fibronectin and c-reactive protein in pregnancy induced hypertension. Jugoslov Med Biohem. 2003;22(4):325– 328. PubMed | Google Scholar

  32. Ali MA, Hameed BH, Kamel WM. The association of serum cancer antigen 125 and c – reactive protein level with the severity of preeclampsia. Karbala J Med. 2012;5(1):1322-28. PubMed | Google Scholar

  33. Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. BJOG. 2002 Mar;109(3):297-301. PubMed | Google Scholar

  34. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol. 2003;59(1):29-37. PubMed | Google Scholar